Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2004

01-06-2004 | Original Article

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer

A hellenic cooperative oncology group phase III study

Authors: George Fountzilas, MD, Elisabeta Ciuleanu, Urania Dafni, George Plataniotis, Anna Kalogera-Fountzila, Epaminontas Samantas, Eleni Athanassiou, John Tzitzikas, Tudor Ciuleanu, Angelos Nikolaou, Panayiotis Pantelakos, Thomas Zaraboukas, Nikolaos Zamboglou, John Daniilidis, Nicolas Ghilezan

Published in: Medical Oncology | Issue 2/2004

Login to get access
Metadata
Title
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer
A hellenic cooperative oncology group phase III study
Authors
George Fountzilas, MD
Elisabeta Ciuleanu
Urania Dafni
George Plataniotis
Anna Kalogera-Fountzila
Epaminontas Samantas
Eleni Athanassiou
John Tzitzikas
Tudor Ciuleanu
Angelos Nikolaou
Panayiotis Pantelakos
Thomas Zaraboukas
Nikolaos Zamboglou
John Daniilidis
Nicolas Ghilezan
Publication date
01-06-2004
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/2004
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:21:2:095

Other articles of this Issue 2/2004

Medical Oncology 2/2004 Go to the issue

Original Article

The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin’s lymphoma patients

Original Article

Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Letter

Rituximab-induced tumor progression

Original Article

Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats

BookReview

Book review

Original Article

Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits